Advanced Pathology Solutions Settles Federal DOJ Probe

The North Little Rock company emphasized that it cooperated fully throughout the government’s review. According to CEO Kevin Hannah, the resolution allows the firm to move past a lengthy period of scrutiny and return its full attention to supporting physicians and patients nationwide. While the settlement brings the investigation to a close, APS maintains that it denies the allegations brought against its previous operational practices.

To move forward, APS has dedicated significant resources toward bolstering its internal compliance infrastructure. The company intends to continue refining these oversight programs to ensure ongoing transparency and strict adherence to federal healthcare requirements. Hannah noted that the organization is prepared to turn the page, characterizing the settlement as a milestone in the company’s efforts to build a more robust, compliance-focused service model.